Funny memes may help people cope with the stress of the COVID-19 pandemic, making viewers feel calmer and more content, according to research published by the American Psychological Association. Looking...

A team of scientists recently conducted a large-scale study at Northwell Health, New York, USA, to evaluate the efficacy of neutralizing monoclonal antibody (MAB) therapies in preventing disease progression...

The coronavirus disease 2019 (COVID-19) pandemic continues to ravage worldwide, infecting over 118.15 million people. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the infection...

Researchers in the United States say the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant – P.1 – that has recently emerged in Brazil shows a worrying level of resistance...

New York has the first case of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant called B.1.526, picked up by genomic surveillance research from Columbia University. The findings...

A Mason Engineering researcher has discovered that artificial microswimmers accumulate where their speed is minimized, an idea that could have implications for improving the efficacy of targeted cancer...

A three-month interval between the first and second doses of the ChAdOx1 nCoV-19 Oxford vaccine results in higher vaccine efficacy than a six-week interval, according to a study published online Feb....

Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the disease. New research led by researchers at King's College London and published in the...

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible...

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. IBRANCE® Palbociclib Consumer Medicine Information What is in this leaflet This leaflet answers some...